Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

100.66
-0.8761-0.86%
Volume:31.30K
Turnover:3.15M
Market Cap:1.61B
PE:9.38
High:101.91
Open:101.91
Low:100.34
Close:101.53
52wk High:108.66
52wk Low:69.02
Shares:16.00M
Float Shares:16.00M
Volume Ratio:1.53
T/O Rate:0.20%
Dividend:1.47
Dividend Rate:1.46%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Sep 11

Growth Without AI: 8 Stock Picks

Dow Jones
·
Sep 11

Top Bristol-Myers Squibb Executive Makes Major Move With Insider Stock Sale

TIPRANKS
·
Sep 11

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Bristol Myers’ EVP, Chief Medical Officer Cristian Massacesi Disposes of 6,249 Common Shares Worth $403,700.93

Reuters
·
Sep 11

Champions Oncology Q1 Revenue Rises on Research Services Business

Reuters
·
Sep 11

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Sep 11

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

Dow Jones
·
Sep 11

Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings

Dow Jones
·
Sep 11

BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod

TIPRANKS
·
Sep 11

Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors

TIPRANKS
·
Sep 11

Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors

TIPRANKS
·
Sep 11

Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says

MT Newswires Live
·
Sep 11

Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout

Reuters
·
Sep 10

Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026

Reuters
·
Sep 10

Bristol-Myers Squibb is Maintained at Hold by HSBC

Dow Jones
·
Sep 10

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

TIPRANKS
·
Sep 10

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS
·
Sep 10